|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
N/A
|
National Cancer Institute
|
|
microRNA-155 and Lymphoma
|
1R01CA138747-01A2
|
$308,138
|
Aguiar, Ricardo
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$1,832,019
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Vitamin D Pooling Project
|
ZIA CP010195 10436
|
$337,546
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-41S2
|
$99,294
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-41
|
$2,527,733
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183 00560
|
$113,406
|
Anderson, William
|
DCEG (NCI)
|
|
Chemical Development of Fluorescent Labeling Tags for DNA Damaged Sites
|
1R03CA153936-01
|
$70,287
|
Andreana, Peter
|
WAYNE STATE UNIVERSITY
|
|
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
|
5R01CA092104-07
|
$258,741
|
ANSELL, STEPHEN
|
MAYO CLINIC
|
|
Mechanisms of GVHD
|
5P01CA142106-07
|
$1,916,255
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
5K24CA128953-03
|
$167,791
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$289,223
|
Aplan, Peter
|
CCR (NCI)
|
|
PREDICTING OUTCOME OF EXPERIMENTAL THERAPY IN LYMPHOMAS BY 31P & 1H MRS
|
1R21CA152858-01
|
$184,886
|
Arias-Mendoza, Fernando
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$503,334
|
Arthur, Diane
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
2U10CA045808-24
|
$2,264,660
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Mid-Region AIDS and Cancer Specimen Resource Consortium
|
7U01CA066531-15
|
$716,105
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
Southwest Oncology Group Treatment Grant
|
2U10CA032102-31
|
$10,205,783
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-31S2
|
$1,500,000
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor Banking for the Southwest Oncology Group
|
3U24CA114748-05S1
|
$1,125,491
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings
|
5R01CA121935-05
|
$248,486
|
Barber, Glen
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Molecular Basis of Action of the Putative Oncogene BCL-6
|
5R01CA071540-13
|
$311,085
|
BARDWELL, VIVIAN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Kaiser NHL - Nested Case-Control Study
|
ZIA CP010121 02113
|
$35,055
|
Baris, Dalsu
|
DCEG (NCI)
|
|
Non-Hodgkin's lymphoma pilot study: chemotherapy and blood levels of organochlori
|
ZIA CP010170 02222
|
$22,814
|
Baris, Dalsu
|
DCEG (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-13
|
$360,039
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
|
5R01CA125195-04
|
$312,550
|
BASSING, CRAIG
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-05
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$103,901
|
Bates, Susan
|
CCR (NCI)
|
|
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
|
ZIA BC 010621
|
$571,457
|
Bates, Susan
|
CCR (NCI)
|
|
Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100
|
5R21CA139368-02
|
$169,400
|
BAUM, LINDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Corn Farming Study
|
ZIA CP010119 02075
|
$109,185
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Cancer in professionals exposed to formaldehyde
|
ZIA CP010120 02094
|
$83,613
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Development of cambinol analogues as antilymphoma agents
|
5R01CA129132-03
|
$365,200
|
BEDALOV, ANTONIO
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Oncogenes and oncogenic microRNAs in chicken tumors
|
5R01CA124596-03
|
$334,992
|
Beemon, Karen
|
JOHNS HOPKINS UNIVERSITY
|
|
RBP2 regulation through differential recruitment to genomic loci
|
1R01CA138631-01A1
|
$313,948
|
Benevolenskaya, Elizaveta
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Cancer prevention by indole-3-carbinol via modulation of the epigenome
|
7R21CA135523-02
|
$184,800
|
Benninghoff, Abby
|
UTAH STATE UNIVERSITY
|
|
The Induction of Interferon Regulatory Factor 7 Sumoylation by EBV LMP1
|
1F32CA142132-01A1
|
$52,154
|
Bentz, Gretchen
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA022453-28S2
|
$2,443,826
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant - Team Leadership Award
|
3P30CA022453-28S3
|
$50,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant - Clinical Trials Reporting Supplement (CTRP)
|
3P30CA022453-28S4
|
$99,998
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Molecule-Guided Investigations into p53 Biology
|
ZIA BC 011261
|
$529,336
|
Bernal, Federico
|
CCR (NCI)
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-02
|
$135,505
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients
|
5R01CA122645-03
|
$317,913
|
BERNSTEIN, STEVEN
|
UNIVERSITY OF ROCHESTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|